Related references
Note: Only part of the references are listed.Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment
Nichola Cooper et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
IL-10 and IL-17 expression by CD4+T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP)
Madeleine L. Stimpson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
Indraraj Umesh Doobaree et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial
Julie Pell et al.
BMJ OPEN (2018)
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?
Cindy E. Neunert
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
Yu Wei et al.
BLOOD (2016)
Mycophenolate mofetil for the treatment of children withimmune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology
Maurizio Miano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Fatigue in immune thrombocytopenia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Mycophenolate mofetil therapy for severe immune thrombocytopenia
Alice Taylor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
Muna Iraqi et al.
HAEMATOLOGICA (2015)
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
Muna Iraqi et al.
HAEMATOLOGICA (2015)
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2014)
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Guillaume Moulis et al.
BLOOD (2014)
T cell immune abnormalities in immune thrombocytopenia
Xuebin Ji et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir et al.
BLOOD (2013)
Cellular immune dysfunction in immune thrombocytopenia (ITP)
Christopher G. J. McKenzie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Understanding the Importance of Using Patient-Reported Outcome Measures in Patients With Immune Thrombocytopenia
Monika Kirsch et al.
SEMINARS IN HEMATOLOGY (2013)
Development of a self-report measure of capability wellbeing for adults: the ICECAP-A
Hareth Al-Janabi et al.
QUALITY OF LIFE RESEARCH (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Fatigue in adult patients with primary immune thrombocytopenia
Julia L. Newton et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults
M. Colovic et al.
PLATELETS (2011)
Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia
James Signorovitch et al.
QUALITY OF LIFE RESEARCH (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura
D Provan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study
R Kotb et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura
WG Zhang et al.
ACTA PHARMACOLOGICA SINICA (2005)
Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura
M Hou et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura
J Howard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)